Literature DB >> 35604210

Determining Susceptibility in Candida Vaginal Isolates.

Jack D Sobel1, Robert Akins2.   

Abstract

Antifungal drug susceptibility tests (AST) for Candida albicans are increasingly demanded for women with refractory or recurrent Candida vaginitis due to fluconazole resistance. Given reduced activity of azole drugs at pH levels found in women with Candida vaginitis, it is proposed that AST be performed at pH 4.5, since testing at only the recommended pH 7.0 is likely to miss a significant number of clinically relevant azole-resistant C. albicans vaginal isolates.

Entities:  

Keywords:  Candida albicans; antifungal drug resistance; antifungal susceptibility tests; fluconazole; pH; susceptibility tests

Mesh:

Substances:

Year:  2022        PMID: 35604210      PMCID: PMC9211391          DOI: 10.1128/aac.02366-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  13 in total

Review 1.  Recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel
Journal:  Am J Obstet Gynecol       Date:  2015-07-09       Impact factor: 8.661

Review 2.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 3.  How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).

Authors:  M C Arendrup; N Friberg; M Mares; G Kahlmeter; J Meletiadis; J Guinea
Journal:  Clin Microbiol Infect       Date:  2020-06-17       Impact factor: 8.067

4.  Fluconazole-resistant Candida albicans vulvovaginitis.

Authors:  Dror Marchaim; Leslie Lemanek; Suchitha Bheemreddy; Keith S Kaye; Jack D Sobel
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

5.  The trailing end point phenotype in antifungal susceptibility testing is pH dependent.

Authors:  K A Marr; T R Rustad; J H Rex; T C White
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Impact of pH on the antifungal susceptibility of vaginal Candida albicans.

Authors:  Wei Liu; Xu Zhang; Zhaohui Liu; Xin Luo
Journal:  Int J Gynaecol Obstet       Date:  2011-06-21       Impact factor: 3.561

7.  Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans.

Authors:  Laura M Collins; Rachelle Moore; Jack D Sobel
Journal:  J Low Genit Tract Dis       Date:  2020-01       Impact factor: 1.925

8.  Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.

Authors:  Mark Spitzer; Nathan P Wiederhold
Journal:  J Low Genit Tract Dis       Date:  2018-04       Impact factor: 1.925

9.  A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections.

Authors:  Sanyuktha Tulasidas; Pooja Rao; Sevitha Bhat; Radhakrishna Manipura
Journal:  Infect Drug Resist       Date:  2018-11-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.